Predicted protein targets (top 16)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MTOR | P42345 | 1/20 | 0.68 |
| ▸ | ROCK2 | O75116 | 2/20 | 0.48 |
| ▸ | ROCK1 | Q13464 | 2/20 | 0.48 |
| ▸ | POLB | P06746 | 1/20 | 0.45 |
| ▸ | ATM | Q13315 | 2/20 | 0.44 |
| ▸ | HSP90AA1 | P07900 | 1/20 | 0.44 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.44 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.44 |
| ▸ | NPY5R | Q15761 | 6/20 | 0.44 |
| ▸ | LMNA | P02545 | 1/20 | 0.42 |
| ▸ | HTT | P42858 | 1/20 | 0.42 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.42 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.42 |
| ▸ | NPY2R | P49146 | 1/20 | 0.42 |
| ▸ | GAA | P10253 | 1/20 | 0.41 |
| ▸ | ALOX5 | P09917 | 1/20 | 0.41 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL22414240 | 1.00 | MTOR (0.68) | MTORROCK2ROCK1POLBATM | |
| SCHEMBL22414266 | 0.86 | MTOR (0.49) | MTORPOLBATMHSP90AA1CYP3A4 | |
| SCHEMBL22414278 | 0.86 | MTOR (0.54) | MTORROCK2ROCK1POLBHTT | |
| SCHEMBL24574875 | 0.84 | MTOR (0.66) | MTORROCK2ROCK1LMNASMN1; SMN2 | |
| SCHEMBL22414270 | 0.82 | ATM (0.46) | MTORPOLBATMHSP90AA1CYP3A4 | |
| SCHEMBL24777791 | 0.81 | MTOR (1.00) | MTORROCK2ROCK1NPY5RNPY2R | |
| SCHEMBL24575427 | 0.80 | MTOR (0.46) | MTORROCK2ROCK1NPY5RLMNA | |
| SCHEMBL22414244 | 0.79 | MTOR (0.59) | MTORROCK2ROCK1CYP2C19NPY5R | |
| SCHEMBL22414276 | 0.79 | MTOR (0.82) | MTORROCK2ROCK1NPY5RSMN1; SMN2 | |
| SCHEMBL24575748 | 0.78 | MTOR (0.58) | MTORROCK2ROCK1LMNASMN1; SMN2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 13 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20240317917-A1 | METHODS FOR HYDROAMINOALKYLATION OF OLEFINS AND GROUP 4 METAL COMPLEXES USEFUL IN SUCH METHODS | UNIV BRITISH COLUMBIA (CA) | 2024-09-26 | — | — | US | disclosed |
| US-11795315-B2 | Group 5 metal complexes for producing amine-functionalized polyolefins | THE UNIVERSITY OF BRITISH COLUMBIA (CA) | 2023-10-24 | — | — | US | disclosed |
| US-11795315-B2 | Group 5 metal complexes for producing amine-functionalized polyolefins | THE UNIVERSITY OF BRITISH COLUMBIA (CA) | 2023-10-24 | — | — | US | disclosed |
| US-11795315-B2 | Group 5 metal complexes for producing amine-functionalized polyolefins | THE UNIVERSITY OF BRITISH COLUMBIA (CA) | 2023-10-24 | — | — | US | disclosed |
| US-20220363786-A1 | GROUP 5 METAL COMPLEXES FOR PRODUCING AMINE-FUNTIONALIZED POLYOLEFINS | THE UNIVERSITY OF BRITISH COLUMBIA (CA) | 2022-11-17 | — | — | US | disclosed |
| US-20220363786-A1 | GROUP 5 METAL COMPLEXES FOR PRODUCING AMINE-FUNTIONALIZED POLYOLEFINS | THE UNIVERSITY OF BRITISH COLUMBIA (CA) | 2022-11-17 | — | — | US | disclosed |
| WO-2022133594-A1 | METHODS FOR HYDROAMINOALKYLATION OF OLEFINS AND GROUP 4 METAL COMPLEXES USEFUL IN SUCH METHODS | THE UNIVERSITY OF BRITISH COLUMBIA (CA) | 2022-06-30 | — | — | WO | disclosed |
| WO-2022133594-A1 | METHODS FOR HYDROAMINOALKYLATION OF OLEFINS AND GROUP 4 METAL COMPLEXES USEFUL IN SUCH METHODS | THE UNIVERSITY OF BRITISH COLUMBIA (CA) | 2022-06-30 | — | — | WO | disclosed |
| US-11034707-B2 | Group 5 metal complexes for catalytic amine functionalization | THE UNIVERSITY OF BRITISH COLUMBIA (CA) | 2021-06-15 | — | — | US | disclosed |
| US-11034707-B2 | Group 5 metal complexes for catalytic amine functionalization | THE UNIVERSITY OF BRITISH COLUMBIA (CA) | 2021-06-15 | — | — | US | disclosed |
| US-20200283459-A1 | GROUP 5 METAL COMPLEXES FOR CATALYTIC AMINE FUNCTIONALIZATION | THE UNIVERSITY OF BRITISH COLUMBIA (CA) | 2020-09-10 | — | — | US | disclosed |
| US-20200283459-A1 | GROUP 5 METAL COMPLEXES FOR CATALYTIC AMINE FUNCTIONALIZATION | THE UNIVERSITY OF BRITISH COLUMBIA (CA) | 2020-09-10 | — | — | US | disclosed |
| WO-2018213938-A1 | GROUP 5 METAL COMPLEXES FOR CATALYTIC AMINE FUNCTIONALIZATION | THE UNIVERSITY OF BRITISH COLUMBIA (CA) | 2018-11-29 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20200283459-A1 | GROUP 5 METAL COMPLEXES FOR CATALYTIC AMINE FUNCTIONALIZATION | ADH5, PRMT5, MAOA | MTOR 4718/4885ROCK2 4118/4885ROCK1 3708/4885 |
| US-11034707-B2 | Group 5 metal complexes for catalytic amine functionalization | ADH5, PRMT5, MAOA | MTOR 4718/4885ROCK2 4118/4885ROCK1 3708/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.